These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 3450522

  • 1. The use of nitrendipine in the treatment of elderly hypertensives.
    Pandita-Gunawardena ND, Macdonald G.
    Eur Heart J; 1987 Nov; 8 Suppl K():57-62. PubMed ID: 3450522
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of nitrendipine in the treatment of elderly hypertensive subjects, and its effect on cerebral blood flow.
    Pandita-Gunawardena ND, Dorrance DE, MacDonald G.
    J Cardiovasc Pharmacol; 1989 Nov; 14 Suppl 10():S52-8. PubMed ID: 2483572
    [Abstract] [Full Text] [Related]

  • 3. Systolic blood pressure reduction with olmesartan medoxomil versus nitrendipine in elderly patients with isolated systolic hypertension.
    Mallion JM, Heagerty A, Laeis P.
    J Hypertens; 2007 Oct; 25(10):2168-77. PubMed ID: 17885562
    [Abstract] [Full Text] [Related]

  • 4. Antihypertensive effects of trandolapril and nitrendipine in the elderly: a controlled trial with special emphasis on time effect profiles.
    Zannad F, Vaur L, Dutrey-Dupagne C, Genes N, Clerson P.
    J Hum Hypertens; 1996 Jan; 10(1):51-5. PubMed ID: 8642191
    [Abstract] [Full Text] [Related]

  • 5. Nitrendipine as an antihypertensive agent.
    Zachariah PK.
    Eur Heart J; 1987 Nov; 8 Suppl K():63-7. PubMed ID: 3330031
    [Abstract] [Full Text] [Related]

  • 6. Control of hypertension in elderly patients with felodipine and metoprolol: a double-blind, placebo-controlled clinical trial.
    Freeling P, Davis RH, Goves JR, Burton RH, Orme-Smith EA.
    Br J Clin Pharmacol; 1987 Oct; 24(4):459-64. PubMed ID: 3318897
    [Abstract] [Full Text] [Related]

  • 7. Amiloride compared with nitrendipine in treatment of essential hypertension.
    Katzman PL, Henningsen NC, Hulthén UL.
    J Hum Hypertens; 1988 Oct; 2(3):147-51. PubMed ID: 3236318
    [Abstract] [Full Text] [Related]

  • 8. Metabolic effects of nitrendipine.
    Paolisso G, Aceto E, Cennamo G, D'Amore A, Varricchio M.
    Clin Ther; 1991 Oct; 13(6):695-8. PubMed ID: 1790544
    [Abstract] [Full Text] [Related]

  • 9. Nitrendipine once or twice daily in hypertensive non-insulin-dependent diabetes mellitus.
    Dolben J, Vora J, Smith H, Luzio S, Griffiths D, Vølund A, Owens DR.
    J Cardiovasc Pharmacol; 1991 Oct; 18 Suppl 1():S94-7. PubMed ID: 1723468
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of once daily nitrendipine in mild hypertension: comparison with placebo.
    Fodor JG, Chockalingam A, Cifkova R, Strong HA, Cobby J, Mukherjee J.
    Can J Cardiol; 1991 Jun; 7(5):223-8. PubMed ID: 1860094
    [Abstract] [Full Text] [Related]

  • 11. Once- vs. twice-daily nitrendipine in the treatment of mild to moderate hypertension, Canadian Nitrendipine Study Group.
    Bolli P, Cobby J, Handa SP, Laplante LE, Mukherjee J, Rabin EZ, Strong HA, Wright JM.
    J Cardiovasc Pharmacol; 1991 Jun; 17 Suppl 2():S182-5. PubMed ID: 1715478
    [Abstract] [Full Text] [Related]

  • 12. Nitrendipine in older patients with isolated systolic hypertension: second progress report on the SYST-EUR trial.
    Staessen J, Bert P, Bulpitt C, De Cort P, Fagard R, Fletcher A, Kivinen P, Lehtomaki E, Leonetti G, O'Brien E.
    J Hum Hypertens; 1993 Jun; 7(3):265-71. PubMed ID: 8345494
    [Abstract] [Full Text] [Related]

  • 13. Nitrendipine 20 mg once daily versus nicardipine slow release 40 mg twice daily in mild essential hypertension: evaluation by 24-hour ambulatory blood pressure monitoring.
    Fogari R, Tettamanti F, Zoppi A, Poletti L, Malamani GD, Corradi L, Borgnino C.
    Clin Exp Hypertens A; 1992 Jun; 14(4):587-96. PubMed ID: 1628410
    [Abstract] [Full Text] [Related]

  • 14. [Monotherapy with the ACE-inhibitor ramipril or the calcium antagonist nitrendipine in essential hypertension].
    Weidmann P, Frank J, Graf W, Hausammann R, Heuberger T, Kerkhoven P, Probst G, Schudel P, Steinbach C, Müller A.
    Schweiz Med Wochenschr; 1992 Oct 03; 122(40):1497-503. PubMed ID: 1411408
    [Abstract] [Full Text] [Related]

  • 15. Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years.
    Kisicki JC, Fiske K, Lyne A.
    Clin Ther; 2007 Sep 03; 29(9):1967-79. PubMed ID: 18035196
    [Abstract] [Full Text] [Related]

  • 16. Nitrendipine and atenolol in essential hypertension in young and middle-aged patients: effect on serum lipids and left ventricular mass.
    López NC, Corral JL, Rincón LA, Arreaza MR, Giralt J, Galué GA, Barrios YE, Arocha I.
    J Cardiovasc Pharmacol; 1991 Sep 03; 18 Suppl 1():S101-5. PubMed ID: 1723446
    [Abstract] [Full Text] [Related]

  • 17. Arterial and antihypertensive effects of nitrendipine: a double-blind comparison versus placebo.
    Asmar R, Benetos A, Brahimi M, Chaouche K, Safar M.
    J Cardiovasc Pharmacol; 1992 Dec 03; 20(6):858-63. PubMed ID: 1282585
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of once daily nitrendipine in essential hypertension--a study using ambulatory blood pressure monitoring.
    Lazarus JH, Littley MD, Phillips DI.
    J Hum Hypertens; 1988 Oct 03; 2(3):191-4. PubMed ID: 3236323
    [Abstract] [Full Text] [Related]

  • 19. A placebo-controlled dose-response study of felodipine extended release in hypertensive patients.
    Liedholm H, Melander A.
    J Cardiovasc Pharmacol; 1989 Jul 03; 14(1):109-13. PubMed ID: 2475701
    [Abstract] [Full Text] [Related]

  • 20. A double-blind, randomized, comparative study of nitrendipine and enalapril in elderly hypertensive patients.
    Poncelet P, Werquin S, Warembourg A, Ansquer JC, Boussac I, Lekieffre J, Carre A.
    J Cardiovasc Pharmacol; 1991 Jul 03; 18 Suppl 1():S67-70. PubMed ID: 1723461
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.